Navigation Links
Study shows blood markers can help choose best dose for antiangiogenic drugs
Date:10/25/2007

that, in addition to the molecular changes observed in the clinic, there were many other proteins that were also elevated after treatment. Ironically, many of these have been shown to have angiogenesis promoting properties and Kerbels team is now investigating the possible implications of these findings. The fact that these molecular changes occur independent of the tumor and involve many proteins that are unrelated to the drug activity, could explain why they have not been useful so far as predictors of patient benefit. They could also contribute to some of the observed drug associated toxicities seen with these drugs, play a role in drug resistance, and even may explain some recent observations where tumors rapidly regrow in some patients when therapy is stopped, using antiangiogenic drugs says Dr. Kerbel, who is also a professor in the Departments of Medical Biophysics and Laboratory Medicine/Pathobiology at University of Toronto. We are testing these hypotheses now.

In the study, the research team used a class of drugs designed to block the activation of receptors (known as receptor tyrosine kinase inhibitors, or RTKIs) activated by an important regulator of angiogenesis called vascular endothelial growth factor (VEGF). The drug they used is called sunitinib which is used for the treatment of kidney cancer, and is now being evaluated for its effects on many other types of cancer. Dr. Kerbels results have led to collaborations between his team and several medical oncologists leading clinical trials at Sunnybrooks Odette Cancer Centre involving late stage kidney cancer and early stage breast cancer therapy with the aim to determine if these preclinical findings are observed in patients, and if so, how the results might be exploited in the future to improve the benefits of antiangiogenic drugs for cancer treatment. This is a major goal of the Toronto Angiogenesis Research Centre established at Sunnybrook with the support of an infrastructure grant from th
'/>"/>

Contact: Natalie Chung-Sayers
natalie.chung-sayers@sunnybrook.ca
416-480-4040
Sunnybrook Health Sciences Centre
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Rural Canadians travel far for specialists: study
2. A new study surpasses Gene Therapy Hurdle
3. Tomato Sauce reduces Cancer Risk- Study
4. A question on study of Adult Stem Cell
5. Study on obesity and heart failure
6. National Lung Study in the process
7. Marijuana gateway theory strengthened by study of twins
8. Old theory of adaptation confirmed by new study
9. Study casts doubt on keyboard ills
10. Gene study links endometriosis, infertility
11. Study reveals how stress can make you sick
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... August 29, 2015 , ... ProDrop Particles includes over 40 ... contains 15 seconds of unique footage that users can shrink and stretch in the ... and more. Users can customize color, brightness, scale, speed, range, and flare attributes with ...
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health ... and sell Arterosil and Arterosil HP, and that all claims and counterclaims have ... Health Sciences, LLC (VHS) in the United States District Court for the Southern ...
(Date:8/28/2015)... ... August 28, 2015 , ... Approximately 2,000 ... Zoo to celebrate children helping children, a thank you to the many creative ... have contributed to the United Methodist initiative to end malaria deaths. , The ...
(Date:8/28/2015)... ... , ... For Dallas, the time is nearing for the annual Heart Walk, ... , The American Heart Association hosts their well-known Heart Walk to raise money in ... difference can be made. Walkers can participate in the cause and someone can also ...
(Date:8/28/2015)... ... August 28, 2015 , ... On May 30th, 2015, Best Drug Rehabilitation, ... the “Music With A Mission” benefit concert in Mendon, IL. Held in the Show ... money to support music education programs in the underfunded local school districts of Mendon ...
Breaking Medicine News(10 mins):Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2
... July 12 Volunteers and staff of the,American Heart ... Michael E. DeBakey, who died yesterday at the age ... cardiovascular medicine and is,personally responsible for developing the field ... American Heart Association.,"He single-handedly started surgery of the aorta, ...
... Care for Military, Vets, All Americans, WASHINGTON, July ... joined with national leaders in offering,condolences to the family ... medical pioneer with long ties to the Department,of Veterans ... DeBakey,s skills as a surgeon and manager, along with ...
... meets with President Sirleaf while part of Mercy Ships Crew ... ... Recently returned from a week-long international humanitarian mission to support Mercy ... upcoming NFL training camp with an additional sense of purpose knowing ...
... VNUS(R) Medical,Technologies, Inc. (Nasdaq: VNUS ), a ... of venous reflux disease, announced,today the resignation of Kathleen ... served on VNUS, Board of Directors since April 1997 ... that funded the company during,its start-up activities. There are ...
... assessment tool, SNPs made no difference, study finds , , ... predicting one,s chances of developing breast cancer do not ... some genetic markers for the disease, a new report ... (SNPs) that indicate a small but statistically significant increase ...
... $850 million in cuts, WASHINGTON, July 11 ... important benefits and pay more out of,pocket for ... Medicare,Advantage plan altogether under legislation approved this week ... would cut nearly $14 billion from the,Medicare Advantage ...
Cached Medicine News:Health News:American Heart Association Saddened by Death of Surgical Pioneer Michael E. DeBakey 2Health News:Redskins' Draft Pick Malcolm Kelly Energized By Trip To Mercy Ship In Liberia 2Health News:Redskins' Draft Pick Malcolm Kelly Energized By Trip To Mercy Ship In Liberia 3Health News:VNUS Medical Technologies, Inc. Announces Board of Director Resignation 2Health News:Recent Genetic Discoveries Don't Improve Prediction of Breast Cancer 2Health News:Pennsylvania Seniors' Medicare Advantage Benefits at Risk 2
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015  Perrigo Company ... that it has completed the acquisition of leading OTC ... at €200 million. The transaction is a clear demonstration ... the Company,s leading European distribution network spanning 36 countries.  ... Joseph C. Papa commented, "We are excited to ...
(Date:8/28/2015)... , August 28, 2015 The ... Livestock (Pork/Swine, Poultry, Ruminant, and Aquaculture), & by Region ( ... Asia-Pacific , and Rest of the World) ... The global market for Eubiotics was valued at USD 4.62 ... Billion by 2020, at a CAGR of 7.4% from 2015 ...
(Date:8/27/2015)... 2015  The Academy of Managed Care Pharmacy ... (FDA,s) draft guidance and proposed rule that calls ... bear a nonproprietary name with an FDA-designated suffix. ... decision from the FDA on the naming issue ... urging the agency to use the same nonproprietary ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2
... Inc., announced today that it has successfully completed a ... Capital on behalf of the MPM Bio IV NVS ... reserves by entering into an agreement with Novartis International ... option to acquire Aires following the successful completion of ...
... Colorectal cancer (CRC) are two words that most people ... 50,000 Americans every year, the disease takes their life. Colorectal ... figure that may dramatically decrease if Americans are regularly screened ... one of the most curable cancers. The U.S. ...
Cached Medicine Technology:Aires Pharmaceuticals, Inc. Completes $20M Equity Financing and Signs an Option Agreement with a Major Pharmaceutical Company 2New Screening Approach FIT to Fight Colorectal Cancer in the U.S. 2New Screening Approach FIT to Fight Colorectal Cancer in the U.S. 3New Screening Approach FIT to Fight Colorectal Cancer in the U.S. 4New Screening Approach FIT to Fight Colorectal Cancer in the U.S. 5
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: